| mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-08 |
| mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
5e-08 |
| mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
4e-06 |
| mRNA |
CUDC-101 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
5e-06 |
| mRNA |
THZ-2-102-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
7e-06 |
| mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-06 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
darinaparsin |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
4e-05 |